Inhibition of human 5-HT3A and 5-HT3AB receptors by etomidate, propofol and pentobarbital

被引：13
|
作者：
Ruesch, Dirk
Braun, Hans A.
Wulf, Hinnerk
Schuster, Anika
Raines, Douglas E.
机构：
[1] Univ Hosp Giessen Marburg GmbH, Dept Anaesthesia & Crit Care, D-35033 Marburg, Germany
[2] Univ Marburg, Inst Physiol & Pathophysiol, Div Neuroendocrinol & Neurodynam, Marburg, Germany
[3] Massachusetts Gen Hosp, Dept Anesthesia & Crit Care, Boston, MA 02114 USA
来源：
EUROPEAN JOURNAL OF PHARMACOLOGY | 2007年 / 573卷 / 1-3期
关键词：
etomidate; propofol; pentobarbital; 5-HT3A receptor; 5-HT3AB receptor;
D O I：
10.1016/j.ejphar.2007.07.009
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
The actions of intravenous anaesthetics on 5-HT3AB receptors have not been studied. Using oocyte electrophysiology, the effects of etomidate, propofol, and pentobarbital on human 5-HT3A and 5-HT3AB receptors were studied and compared. Inhibition of peak currents by all three compounds in both receptor subtypes was anaesthetic concentration-dependant and non-competitive. Because the half-maximal inhibitory concentrations for etomidate, propofol and pentobarbital in 5-HT3A and 5-HT3AB receptors were all above their respective anaesthetic concentrations, the results of our study suggest that neither 5-HT3 receptor subtype contributes to the anaesthetic actions of etomidate, propofol or pentobarbital. (c) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码：60 / 64
页数：5
相关论文
共 50 条
  • [1] Discriminating between 5-HT3A and 5-HT3AB receptors
    Thompson, A. J.
    Lummis, S. C. R.
    BRITISH JOURNAL OF PHARMACOLOGY, 2013, 169 (04) : 736 - 747
  • [2] Activation of the human 5-HT3A and 5-HT3AB receptors by 5-HT and meta-chlorophenylbiguanide
    Michaelson, S. D.
    Dunn, S. M. J.
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2012, 90 (06) : 672 - 673
  • [3] A single channel mutation alters agonist efficacy at 5-HT3A and 5-HT3AB receptors
    Thompson, A. J.
    Lummis, S. C. R.
    BRITISH JOURNAL OF PHARMACOLOGY, 2013, 170 (02) : 391 - 402
  • [4] VUF10166, a Novel Compound with Differing Activities at 5-HT3A and 5-HT3AB Receptors
    Thompson, A. J.
    Verheij, M. H. P.
    de Esch, I. J. P.
    Lummis, S. C. R.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2012, 341 (02): : 350 - 359
  • [5] The binding characteristics and orientation of a novel radioligand with distinct properties at 5-HT3A and 5-HT3AB receptors
    Thompson, Andrew J.
    Verheij, Mark H. P.
    Verbeek, Joost
    Windhorst, Albert D.
    de Esch, Iwan J. P.
    Lummis, Sarah C. R.
    NEUROPHARMACOLOGY, 2014, 86 : 378 - 388
  • [6] Agonists and antagonists induce different palonosetron dissociation rates in 5-HT3A and 5-HT3AB receptors
    Lummis, Sarah C. R.
    Thompson, Andrew J.
    NEUROPHARMACOLOGY, 2013, 73 : 241 - 246
  • [7] Anticancer drug irinotecan inhibits homomeric 5-HT3A and heteromeric 5-HT3AB receptor responses
    Nakamura, Yukiko
    Ishida, Yusuke
    Yamada, Takahiro
    Shimada, Shoichi
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2011, 415 (02) : 416 - 420
  • [8] StructureActivity Relationships of Quinoxaline-Based 5-HT3A and 5-HT3AB Receptor-Selective Ligands
    Thompson, Andrew J.
    Verheij, Mark H. P.
    van Muijlwijk-Koezen, Jacqueline E.
    Lummis, Sarah C. R.
    Leurs, Rob
    de Esch, Iwan J. P.
    CHEMMEDCHEM, 2013, 8 (06) : 946 - 955
  • [9] Pharmacological comparison of human homomeric 5-HT3A receptors versus heteromeric 5-HT3A/3B receptors
    Brady, CA
    Stanford, IM
    Ali, I
    Lin, L
    Williams, JM
    Dubin, AE
    Hope, AG
    Barnes, NM
    NEUROPHARMACOLOGY, 2001, 41 (02) : 282 - 284
  • [10] The effects of morphine on human 5-HT3A receptors
    Wittmann, Maria
    Peters, I.
    Schaaf, T.
    Wartenberg, H. C.
    Wirz, S.
    Nadstawek, J.
    Urban, B. W.
    Barann, M.
    ANESTHESIA AND ANALGESIA, 2006, 103 (03): : 747 - 752
12345